Active Pharmaceutical Ingredients Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Active Pharmaceutical Ingredients stocks.

Active Pharmaceutical Ingredients Stocks Recent News

Date Stock Title
Apr 18 NVS US FDA mandates label updates on CAR-T cancer therapies
Apr 18 CDXS Codexis to Report First Quarter 2024 Financial Results on May 2
Apr 18 TEVA 3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
Apr 18 VTRS 3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
Apr 18 VTRS Bill Miller’s Latest 13 Stock Picks
Apr 18 NVS Exploring Analyst Estimates for Novartis (NVS) Q1 Earnings, Beyond Revenue and EPS
Apr 17 NVS 2 High-Yield Dividend Stocks to Buy and Hold for 10 Years
Apr 17 NVS Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Apr 16 TEVA FDA approves Alvotech biosimilar of J&J top-selling drug Stelara
Apr 16 TEVA Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Apr 16 VTRS Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
Apr 16 NVS Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug
Apr 16 TEVA Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets
Apr 15 TEVA Israeli economy has proven to thrive despite crisis: Expert
Apr 15 NVS New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Apr 15 PRGO Here’s Why Perrigo Company PLC (PRGO) Stock Slumped in Q1
Apr 15 VTRS Viatris Appoints Corinne Le Goff as Chief Commercial Officer
Apr 15 TARO Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Apr 15 VTRS Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada
Apr 15 NVS Antitrust fervor is gripping Washington and Silicon Valley. But lawsuits have been declining.
Active Pharmaceutical Ingredients

An active ingredient (AI) is the ingredient in a pharmaceutical drug or pesticide that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon (from Greek: φάρμακον, adapted from pharmacos) which originally denoted a magical substance or drug.
The terms active constituent or active principle are often chosen when referring to the active substance of interest in a plant (such as salicylic acid in willow bark or arecoline in areca nuts), because the word ingredient in many minds connotes a sense of human agency (that is, something that a person combines with other substances), whereas the natural products present in plants were not added by any human agency but rather occurred naturally ("a plant doesn't have ingredients").
In contrast with the active ingredients, the inactive ingredients are usually called excipients in pharmaceutical contexts. The main excipient that serves as a medium for conveying the active ingredient is usually called the vehicle. Petrolatum and mineral oil are common vehicles.

Browse All Tags